Aviva PLC reduced its stake in shares of Waters Co. (NYSE:WAT - Free Report) by 1.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 111,859 shares of the medical instruments supplier's stock after selling 2,119 shares during the quarter. Aviva PLC owned about 0.19% of Waters worth $41,497,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Bank of Jackson Hole Trust acquired a new position in Waters during the fourth quarter valued at approximately $34,000. Fortitude Family Office LLC boosted its position in shares of Waters by 235.7% during the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after purchasing an additional 66 shares in the last quarter. Steward Partners Investment Advisory LLC grew its holdings in shares of Waters by 129.3% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after buying an additional 53 shares during the period. Murphy & Mullick Capital Management Corp bought a new stake in shares of Waters in the 4th quarter valued at $42,000. Finally, EverSource Wealth Advisors LLC raised its stake in Waters by 54.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier's stock worth $46,000 after buying an additional 44 shares during the period. 94.01% of the stock is owned by institutional investors.
Waters Stock Up 2.1 %
Shares of NYSE:WAT traded up $6.57 during trading on Friday, hitting $321.23. 132,774 shares of the company were exchanged, compared to its average volume of 474,021. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $423.56. The stock has a market cap of $19.08 billion, a price-to-earnings ratio of 29.90, a P/E/G ratio of 3.79 and a beta of 1.04. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. The firm has a fifty day moving average price of $370.49 and a two-hundred day moving average price of $372.47.
Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping analysts' consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. As a group, research analysts anticipate that Waters Co. will post 12.86 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on WAT shares. Wells Fargo & Company raised their price target on Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Sanford C. Bernstein upgraded shares of Waters from a "market perform" rating to an "outperform" rating and set a $430.00 target price on the stock in a report on Friday, January 10th. JPMorgan Chase & Co. upped their price target on shares of Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a report on Thursday, March 6th. Baird R W raised shares of Waters from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, March 26th. Finally, UBS Group boosted their price objective on shares of Waters from $405.00 to $410.00 and gave the company a "neutral" rating in a research report on Thursday, February 13th. Ten investment analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $397.25.
Get Our Latest Stock Report on WAT
Waters Company Profile
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Read More
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
